ViAqua Therapeutics was established in September 2014 to address the growing need for effective, affordable health management of diseases in aquaculture. To date, ViAqua has received investments from The Trendlines Group , Nutreco, VisVires New Protein and the Technion–Israel Institute of Technology, with support from the Israel Innovation Authority.
Spanish Fishing Consortia Impact Artisanal Fishing in Central America Nicaragua
The following is an excerpt from an article published by IPS-Inter Press Service:
Spanish transnational fishing companies, especially in Nicaragua, El Salvador and Guatemala, have aimed to exploit ec...
Vietnam's shrimp exports reached over 686 million USD in Q1/2024 Viet Nam
In March 2024, shrimp exports reached nearly 272 million USD, up 3% over the same period last year. Although the growth rate is still modest, this shows that purchasing power from the markets is recov...
The Norwegian Pelagic Fishing Course in Week 17 Norway
Good week for blue whiting in the Faroese zone, but still poor for the sandeel
Blue whiting:
Last week, 19,499 tonnes of coal mullet were registered from 19 different boats. The fishing has ...
Copyright 1995 - 2024 Seafood Media Group Ltd.| All Rights Reserved. DISCLAIMER